Matches in Wikidata for { <http://www.wikidata.org/entity/Q92191939> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q92191939 description "clinical trial" @default.
- Q92191939 description "ensayo clínico" @default.
- Q92191939 description "ensayu clínicu" @default.
- Q92191939 description "klinisch onderzoek" @default.
- Q92191939 description "клінічне випробування" @default.
- Q92191939 description "կլինիկական փորձարկում" @default.
- Q92191939 name "Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer" @default.
- Q92191939 name "Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer" @default.
- Q92191939 type Item @default.
- Q92191939 label "Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer" @default.
- Q92191939 label "Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer" @default.
- Q92191939 prefLabel "Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer" @default.
- Q92191939 prefLabel "Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer" @default.
- Q92191939 P1132 Q92191939-F2E1B6A2-2F0D-4C41-B561-FA8BDC167929 @default.
- Q92191939 P1476 Q92191939-CD742A01-784A-4422-BF6D-871170A9CA27 @default.
- Q92191939 P2899 Q92191939-F846F2A6-E7DA-4D86-B43B-883C93B19DA1 @default.
- Q92191939 P3098 Q92191939-466222BF-C444-4D92-99A7-DF89DBD05919 @default.
- Q92191939 P31 Q92191939-501DA1A5-0220-4A08-9210-93D0A5FDF1A5 @default.
- Q92191939 P4135 Q92191939-5DA55EDB-A205-4F97-9312-F2246E6F94A3 @default.
- Q92191939 P4844 Q92191939-E0D6A21C-6932-468B-A927-EDA7990DA826 @default.
- Q92191939 P580 Q92191939-E10DBE53-04FD-43E6-B198-924432EBBAB0 @default.
- Q92191939 P582 Q92191939-768269DE-31FB-489C-9F50-47BC41A0A01A @default.
- Q92191939 P6099 Q92191939-A443EBDB-A7D5-46C5-9C49-FE89255BCD2A @default.
- Q92191939 P8363 Q92191939-6D6F4365-953C-411A-9269-676EC3748051 @default.
- Q92191939 P1132 "+30" @default.
- Q92191939 P1476 "A Study on the Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer" @default.
- Q92191939 P2899 "+18" @default.
- Q92191939 P3098 "NCT04345783" @default.
- Q92191939 P31 Q30612 @default.
- Q92191939 P4135 "+75" @default.
- Q92191939 P4844 Q27262801 @default.
- Q92191939 P580 "2018-01-01T00:00:00Z" @default.
- Q92191939 P582 "2021-12-31T00:00:00Z" @default.
- Q92191939 P6099 Q42824440 @default.
- Q92191939 P8363 Q78089383 @default.